Related Experiment Video
Updated: Jan 11, 2026

07:56
A Full Skin Defect Model to Evaluate Vascularization of Biomaterials In Vivo
Published on: August 28, 2014
12.8K
Engineering a heparin-mimetic biomaterial to promote tissue vascularization
Linqing Li1,2,3, Jinling Yang4,5, Luba Perry5
1Department of Biomedical Engineering and the Biological Design Center, Boston University, Boston, MA, USA. Linqing.Li@unh.edu.
Communications Biology
|November 14, 2025
Summary
Researchers created a synthetic heparin-mimetic material for tissue engineering. This biomaterial promotes vascularization without causing bleeding, offering a safer alternative for engineered tissues.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Vascularization is crucial for engineered tissue survival and function.
- Existing pro-angiogenic scaffolds often cause adverse effects like bleeding due to inherent bioactivities.
Purpose of the Study:
- To develop a synthetic biomaterial that mimics heparin's pro-angiogenic properties without its anticoagulant activity.
- To create a tunable scaffold for enhanced vascularization in tissue engineering.
Main Methods:
- Synthesized dextran hydrogels with sulfate adducts to mimic heparin.
- Evaluated the binding and immobilization of growth factors.
- Assessed in vitro vascular network formation and in vivo microvascularization.
- Compared performance against heparin-conjugated hydrogels.
Main Results:
- Heparin-mimetic hydrogels effectively bound growth factors and enhanced angiogenic signaling.
- Promoted robust in vitro vascular network formation and in vivo tissue microvascularization.
- Achieved similar vascularization levels as heparin hydrogels but without inducing local bleeding.
Conclusions:
- Synthetic heparin-mimetic hydrogels decouple pro-angiogenic from anticoagulant effects.
- This novel biomaterial offers a safe and effective approach for vascularizing engineered tissues.
- Provides a tunable platform for advancing tissue engineering and regenerative medicine.

